Athletic nicotine: does a pouch really sharpen your training?

Somewhere between the pre-workout shaker and the nootropic stack, nicotine has been given a makeover. Tobacco-free pouches, tucked under the lip, are now marketed to endurance athletes, weightlifters, esports players and desk-bound optimisers as a clean way to sharpen focus and reaction time. One brand, Athletic Nicotine, is built entirely around the pitch. It is worth asking, calmly, what the evidence actually supports, because the drug being repackaged here is one of the most addictive in common use.

What people think it does

The claimed benefits are razor-sharp focus, faster reactions, steady energy and mental clarity, without the smoke, spit or smell of older tobacco products. Performance-framed pouches usually carry 2 to 6 milligrams of synthetic nicotine, and influencers fold them into stacks alongside caffeine and L-theanine. The framing is wellness. The pharmacology is not new.

What the cognition research actually shows

There is real evidence that nicotine can nudge certain mental tasks. The largest analysis, a meta-analysis of 41 placebo-controlled studies, found nicotine produced significant positive effects in a handful of narrow domains, such as alerting attention, fine motor control and short-term memory. The catch is the size of those effects: 0.16 to 0.44, which is small to moderate. And the benefit is largest in people who are already nicotine-deprived, meaning a chunk of the boost is relief from withdrawal rather than genuine enhancement. A Vanderbilt neuropharmacologist who studies nicotine and cognition has described the effect for a normally functioning person as marginal at best.

There is a deeper problem with the evidence, too. A 2020 systematic review found that studies funded by the tobacco industry are more likely to report favourable cognitive results, which makes the true effect hard to pin down.

For actual athletic performance, the case is weaker still

If the cognitive story is modest, the athletic one barely exists. A review of ten controlled studies on strength, endurance and high-intensity exercise found that seven showed no change, two a benefit and one a harm. Nicotine also constricts blood vessels and raises cardiovascular load, which can work against endurance rather than for it. No nicotine pouch is approved by any regulator as a performance or cognitive product. When the FDA acted on ZYN in 2026, it authorised only a narrow claim that the product is lower risk than cigarettes, and it went out of its way to say the products are not safe.

The cost side of the ledger

This is where the wellness framing gets dangerous. Nicotine is powerfully addictive, and clinicians warn that pouches pose a real risk of dependence for people who never used tobacco, the exact audience the clean, athletic branding pulls in. Unlike nicotine gum sold to help people quit, these pouches are not approved cessation aids. Nicotine acutely raises heart rate and blood pressure and is linked to heart disease. And the population-level worry is youth: US surveys put nicotine-pouch use among students at roughly 1.5 to 2 percent, and the developing adolescent brain is especially vulnerable.

Our take

Strip away the athletic styling and this is nicotine, sold with a small, narrow and short-lived cognitive effect whose evidence base is compromised by industry money, and no reliable athletic benefit at all. Against that sits dependence, higher heart rate and blood pressure, and a heart-disease link. For someone already addicted, a pouch is a lower-risk delivery method than cigarettes. For everyone else, and especially for anyone nicotine-free, the trade is a bad one. Caffeine, sleep and training do more for your performance, and none of them hook you.

This is general information, not medical or cessation advice. Nicotine is addictive; if you use it and want to stop, speak to a clinician or a licensed quit service.